Who it’s for

Three markets.The same five.

Whoever you are, you can ask for all five. The price is the same, the record is the same, and the platform is the same. What changes is who signs the work and who reads it after.

THIS PAGE ANSWERS: IS THIS FOR SOMEONE LIKE ME, AND WHAT CHANGES FOR ME SPECIFICALLY?

THE SAME FOR EVERYONE
Orient / Brief / Panel / Analysis / Mission
Same price, same record, same platform. Mission is in build.
WHAT CHANGES
Life sciences teams
SIGNSYour reviewerREADS ITYour quality unit
PICK YOUR MARKET
FOR PHARMA FUNCTIONS AND SPONSORS

Commission the outcome. Keep the record.

A commissioned deliverable through your services budget: scoped, drafted, gated, signed off, with dissent and trade-offs on the record rather than smoothed out of a slide.

THE SITUATION01
You pay for rediscovery twice.

The payer archetypes get rebuilt from scratch, the evidence standards get rediscovered at review, and the reasoning behind last year's positioning left with the consultant who made it. Once in fees, again in review cycles.

WHAT CHANGES02
Commission an outcome, literally.

You name the outcome, the work decomposes from it, and everything that lands is chained to the evidence beneath it and the decision around it. The next program traverses that chain instead of re-learning it.

GOVERNANCE03
Something your quality function can inspect.

A named reviewer at every gate, the evidence presented, dissent filed as structured data in your own tenant.

WHO SIGNS
Your reviewer
WHO READS IT
Your quality unit
WHAT YOU’RE ALREADY THINKING
The objections, answered.
“We have Copilot, or an internal build.

Keep it, and measure it. The PROOF Assessment runs your current system against a published protocol on your own tasks, your experts grading blind. If your build wins, you will have the record proving it.

“Procurement will take six months.

The entry is a commissioned deliverable through the services budget. A services purchase, not a platform decision.

“We already have a knowledge management system.

And every program still rebuilds the payer archetypes, because a repository stores documents, not the chain from work to outcome to strategy.

“Quality will block it.

Bring them first, not last. Gates that bind a named reviewer, show the evidence, and file dissent are their language.

“Is our data safe?

Tenant-scoped, exportable, permanently yours, under a data processing agreement with Crossroads Catalyst GmbH. Put our data sentence in front of procurement; it survives.

Two people, not organizations

It is also for two individuals.

THE PROFESSIONAL
Whose name goes on the work.

Whatever the badge says, your name goes on work that AI now touches, and nothing in your current toolchain will defend you when someone asks how it was made. On VITAL every deliverable you produce carries its evidence and its record. Your workspace, your precedents and your method travel with you between employers.

If you are employed at a pharma or a payer, your own work and professional development are yours; employer deliverables belong in employer channels. Check your policy, or better, introduce us.

THE METHOD OWNER
Whose method should run when they are not in the room.

Codifying a method is the opposite transaction from buying capacity, so it has its own page rather than a tab in the selector above.

Vex

Put your name on work you can defend.

Join See the price first
FOR CREATORS

Build methods, agents or templates for VITAL? Publish them once in the Studio, and they run on both.